Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 159.9 SEK -0.93% Market Closed
Market Cap: 12.7B SEK
Have any thoughts about
Biotage AB?
Write Note

Biotage AB
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biotage AB
Cash & Cash Equivalents Peer Comparison

Comparables:
ALIF B
BICO
G
GENO
MCAP
M
MAGLE

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Biotage AB
STO:BIOT
Cash & Cash Equivalents
kr370m
CAGR 3-Years
1%
CAGR 5-Years
23%
CAGR 10-Years
17%
AddLife AB
STO:ALIF B
Cash & Cash Equivalents
kr272m
CAGR 3-Years
8%
CAGR 5-Years
35%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cash & Cash Equivalents
kr861m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Cash & Cash Equivalents
kr135.8m
CAGR 3-Years
48%
CAGR 5-Years
72%
CAGR 10-Years
41%
MedCap AB (publ)
STO:MCAP
Cash & Cash Equivalents
kr287.7m
CAGR 3-Years
29%
CAGR 5-Years
76%
CAGR 10-Years
15%
M
Magle Chemoswed Holding AB
STO:MAGLE
Cash & Cash Equivalents
kr7.1m
CAGR 3-Years
5%
CAGR 5-Years
26%
CAGR 10-Years
N/A

See Also

What is Biotage AB's Cash & Cash Equivalents?
Cash & Cash Equivalents
370m SEK

Based on the financial report for Sep 30, 2024, Biotage AB's Cash & Cash Equivalents amounts to 370m SEK.

What is Biotage AB's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
17%

Over the last year, the Cash & Cash Equivalents growth was -26%. The average annual Cash & Cash Equivalents growth rates for Biotage AB have been 1% over the past three years , 23% over the past five years , and 17% over the past ten years .

Back to Top